Catalent Opens Korean Sales Office
PTSM: Pharmaceutical Technology Sourcing and Management
The company opened a new sales office located in Seoul, South Korea.
On May 26, 2016, Catalent Pharma Solutions announced the opening of a new sales office in Korea to support the company’s continued investment in the Asia-Pacific region, the company said in a press announcement. The company’s new sales office will be located in Seoul, South Korea.
In addition to the opening of the new sales office, Catalent has filled two key positions in the Asia pacific region. Howard Kim recently joined the company in the role of director of business development and will work between Catalent’s new sales office in Seoul, and the company’s Somerset, NJ headquarters. Kim will manage business development activities across Catalent’s business units in the Korean market. The company also promoted Erin Vlack to manager of Catalent’s new Clinical Supply Services site in Kakegawa, Japan, which will provide secondary packaging, labeling, and distribution capabilities for the company. Vlack will lead the site’s clinical supply operations.
In the past three years, Catalent has made more than $10 million in capital investments with additional personnel to expand its overall Asia-Pacific footprint to meet growing customer demand. The company’s network spans nine audited depots and three fully-owned and operated clinical packaging facilities in China, Singapore, and Japan when it opens for business later this year. Services include primary and secondary packaging, demand led supply services, clinical storage, cold chain services, global distribution, comparator sourcing, project management, clinical supply management, regulatory consulting, and returns and destruction.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.
